---
title: "触媒制药公司 (CPRX.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/CPRX.US/norm.md"
symbol: "CPRX.US"
name: "触媒制药公司"
parent: "https://longbridge.com/zh-CN/quote/CPRX.US.md"
datetime: "2026-05-20T19:36:06.765Z"
locales:
  - [en](https://longbridge.com/en/quote/CPRX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CPRX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CPRX.US/norm.md)
---

# 触媒制药公司 (CPRX.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | 0.5000 | 0.4100 | 0.4200 | 0.4100 | 0.4500 |
| ROE | 25.92% | 22.49% | 23.77% | 25.26% | 29.82% |
| 营业收入 | 149.39M | 152.61M | 148.39M | 146.56M | 141.42M |
| 净利润 | 63.73M | 52.70M | 52.78M | 52.11M | 56.74M |
| 营业利润 | 73.23M | 61.85M | 66.27M | 66.30M | 63.37M |
| 毛利率 | 88.53% | 81.73% | 82.94% | 82.96% | 84.59% |
| 净利率 | 42.66% | 34.53% | 35.57% | 35.55% | 40.12% |
| 利润含金量 | 122.90% | 137.77% | 204.29% | 92.99% | 105.54% |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 1.15B | 1.10B | 1.05B | 971.91M | 908.87M |
| 权益乘数 | 1.13 | 1.16 | 1.14 | 1.14 | 1.14 |
| 每股净资产 | 8.29 | 7.79 | 7.47 | 6.99 | 6.51 |
| 资产周转率 | 0.5806 | 0.6024 | 0.6341 | 0.6656 | 0.6874 |
| 现金及短投 | 755.86M | 709.17M | 689.89M | 652.80M | 580.66M |
| 存货与应收 | 34.93M | 37.17M | 28.03M | 18.65M | 19.78M |
| 长期投资 | 2.85M | 2.97M | 3.09M | 3.23M | 3.40M |
| 净债务 | -753.18M | -706.38M | -687.00M | -649.81M | -577.57M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | 59.59M | 44.89M | 32.44M | 71.30M | 60.04M |
| 投资现金流 | -27000.00 | -32000.00 | 0.0000 | -26000.00 | - |
| 融资现金流 | -12.87M | -25.58M | 4.65M | 872000.00 | 3.06M |
| 自由现金流 | 47.34M | 49.93M | 15.60M | 58.94M | 46.87M |
| 现金流充裕率 | 220692.59% | 140284.38% | - | 274223.08% | - |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | -27000.00 | -32000.00 | 0.0000 | -26000.00 | - |